As the COVID-19 respiratory virus spreads around the world, please know that the IMF is here for you.
People living with myeloma are at an increased risk. “Myeloma patients have compromised immune systems and are highly vulnerable to new infections,” says IMF Chairman Dr. Brian G.M. Durie.
“It is important to be proactive and guard against infection from unknown sources.”
On this page, you will find updated guidance to keep you safe. Featured are Dr. Durie’s blogs and FAQs, aimed specifically at myeloma patients, and links to the best sources of COVID-19 news.
There is currently no vaccine against COVID-19, so it is important for myeloma patients and their families to minimize their risk for contracting the virus. Practices to minimize your risk include:
- Avoiding close contact with people who are sick. Practice social distancing by staying 6 feet away from others. Isolation at home is best.
- Avoiding touching your eyes, nose, and mouth.
- Clean and disinfect frequently touched objects and surfaces using a regular household cleaning spray or wipe.
- Wash your hands often with soap and water for at least 20 seconds, especially after going to the bathroom; before eating; and after blowing your nose, coughing, or sneezing. If soap and water are not readily available, use an alcohol-based hand sanitizer with at least 60% alcohol.
Please be safe and well, and please contact the IMF InfoLine with any questions.
published March 26, 2020
Dr. Brian Durie answers myeloma patients' top questions.
In this blog, Dr. Brian G.M. Durie answers questions pertaining to myeloma patients about the COVID-19 (coronavirus). Questions include: Should you continue your myeloma treatment? What is the risk of having an ASCT transplant at this time?
As the novel coronavirus spreads across the U.S., avoiding exposure is critical for people living with myeloma. Weakened immune systems make them especially vulnerable to infection. IMF Chairman Dr. Brian G.M. Durie provides an FAQ for myeloma-specific guidance.
In his blog, IMF Chairman of the Board Dr. Brian G.M. Durie provides a timely update on precautions myeloma patients can take to prevent contraction of the coronavirius (COVID-19).
Faced with the alarming news of the 2019 novel coronavirus disease (COVID-19), myeloma patients may be looking for guidance in ways to reduce their risk of exposure. Fortunately, there are many up-to-the-minute resources that spell out best practices during this fast-moving story, including Dr. Brian G.M. Durie’s blog.
We wanted to take some time and keep you up to date on the Federal Government’s response regarding COVID-19. We have received a lot of questions from patients and their families about what is included in the government has done to address the virus.
COVID-19 External Resources:
- World Health Organization
- Centers for Disease Control
- FDA: A Message to Patients With Cancer and Health Care Providers About COVID-19
- FDA Issues Guidance for Conducting Clinical Trials
- US Government Response
- Global Dashboard of confirmed cases
- Medicare and Medicaid
- VA and Coronavirus
- The American Red Cross: Steps to Help Cope with the Evolving Coronavirus Situation
- Multiple Myeloma Medicare Access
- COVID-19 Ancillary Costs
The International Myeloma Foundation medical and editorial content team
Comprised of leading medical researchers, hematologist, oncologists, oncology-certified nurses, medical editors, and medical journalists, our team has extensive knowledge of the multiple myeloma treatment and care landscape. Additionally, Dr. Brian G.M. Durie reviews and approves all medical content on this website.
Last Medical Review: March 21, 2020